| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytokinetics, Incorporated (CYTK) have been net sellers, shedding 76,163 shares worth roughly $6.0M on balance. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), CYTK's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.57M | - | |
| VP | 157.4K | $12.81M | -3,500 | |
| CFO | 100.8K | $8.21M | - | |
| Other | 87.3K | $7.10M | - | |
| VP | 58.6K | $4.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Harrington Robert Arthur51 | Director | Sell | 900 | $42.50 | $38,250.00 | -5.6% | -28.6% | +42.5% | |
| Mar 3, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 2,449 | $42.88 | $105,013.12 | -2.1% | -27.2% | +41.5% | |
| Mar 3, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 1,114 | $42.88 | $47,768.32 | -1.6% | -27.2% | +41.5% | |
| Mar 3, 2025 | Blum Robert I50 | President &CEO | Sell | 8,743 | $42.88 | $374,899.84 | -2.1% | -27.2% | +41.5% | |
| Feb 18, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $45.98 | $91,960.00 | -1.7% | -32.3% | +47.6% | |
| Feb 4, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $48.06 | $96,120.00 | -1.7% | -25.5% | +29.1% | |
| Jan 21, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $45.92 | $91,840.00 | -1.7% | -17.2% | +37.6% | |
| Jan 7, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $49.32 | $98,640.00 | -1.7% | -25.8% | +34.9% | |
| Dec 16, 2024 | Wierenga Wendall59 | Director | Sale+OE | 742 | $48.61 | $36,068.62 | -2.9% | -8.4% | +26.5% | |
| Dec 11, 2024 | Henderson John T65 | Director | Sale+OE | 1,780 | $50.42 | $89,747.60 | -4.4% | -12.4% | +19.9% |